Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AgfiledCriticalNovartis Ag
Priority to HN2009003408ApriorityCriticalpatent/HN2009003408A/es
Publication of HN2009003408ApublicationCriticalpatent/HN2009003408A/es
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
LA INVENCION SE REFIERE A COMPOSICIONES Y METODOS PARA MODULAR LA EXPRESION DE ALFA-ENAC, Y MAS PARTICULARMENTE A LA DISMINUCION DE LA EXPRESION DE ALFA-ENAC MEDIANTE ALIGONUCLEOTIDOS QUIMICAMENTE MODIFICADOS.
HN2009003408A2009-12-142009-12-14Inhibicion de arni de expresion de alfa-enac
HN2009003408A
(es)